A COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETERMINATION OF N-ACETYLTRANSFERASE (NAT2) PHENOTYPES

被引:8
作者
WONG, P [1 ]
LEYLANDJONES, B [1 ]
WAINER, IW [1 ]
机构
[1] MCGILL UNIV,DEPT ONCOL,MONTREAL,PQ,CANADA
关键词
5-ACETYLAMINO-6-AMINO-3-METHYLURACIL; CAFFEINE METABOLITES; IMMUNOASSAY; 1-METHYLXANTHINE; N-ACETYLATOR PHENOTYPING; PHARMACOKINETICS;
D O I
10.1016/0731-7085(95)01550-5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The ratio of 5-acetylamino-6-amino-3-methyluracil (AAMU) to l-methylxanthine (1X) in urine samples after caffeine ingestion can be used to indicate human N-acetyltransferase (NAT2) phenotypes. In previous studies, this ratio has been determined by LC or capillary electrophoresis. The possibility that this ratio could be determined by competitive antigen enzyme linked immunosorbent assays (ELISAs) has been investigated. Polyclonal antibodies were raised in rabbits against synthetic derivatives of AAMU and 1X, and competitive antigen ELISAs were developed after isolation of the IgGs by ion-exchange chromatography. The competitive antigen ELISA correctly identified previously determined NAT2 phenotypes and gave the expected distribution of slow and fast N-acetylators within a group of 48 individuals.
引用
收藏
页码:1079 / 1086
页数:8
相关论文
共 21 条
[1]   CAFFEINE METABOLISM IN A HEALTHY SPANISH POPULATION - N-ACETYLATOR PHENOTYPE AND OXIDATION PATHWAYS [J].
CARRILLO, JA ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (03) :293-304
[2]   GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].
CLARK, DWJ .
DRUGS, 1985, 29 (04) :342-375
[3]   ACETYLATOR PHENOTYPES OF SAUDI ARABIANS BY A SIMPLIFIED CAFFEINE METABOLITES TEST [J].
ELYAZIGI, A ;
CHALEBY, K ;
MARTIN, CR .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (03) :246-250
[4]  
ERLANGER BF, 1957, J BIOL CHEM, V228, P713
[5]   DEVELOPMENT OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR CAFFEINE [J].
FICKLING, SA ;
HAMPTON, SM ;
TEALE, D ;
MIDDLETON, BA ;
MARKS, V .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 129 (02) :159-164
[6]  
FINK K, 1964, J BIOL CHEM, V249, P4250
[7]  
GASCON MP, 1987, SCHWEIZ MED WSCHR, V117, P197
[8]   ACETYLATION PHARMACOGENETICS - THE SLOW ACETYLATOR PHENOTYPE IS CAUSED BY DECREASED OR ABSENT ARYLAMINE N-ACETYLTRANSFERASE IN HUMAN LIVER [J].
GRANT, DM ;
MORIKE, K ;
EICHELBAUM, M ;
MEYER, UA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :968-972
[9]   ACETYLATOR PHENOTYPING VIA ANALYSIS OF 4 CAFFEINE METABOLITES IN HUMAN URINE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY WITH MULTIWAVELENGTH DETECTION [J].
GUO, R ;
THORMANN, W .
ELECTROPHORESIS, 1993, 14 (5-6) :547-553
[10]   DETERMINATION OF ACETYLATOR PHENOTYPE IN CAUCASIANS WITH CAFFEINE [J].
HILDEBRAND, M ;
SEIFERT, W .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (05) :525-526